Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Susceptibility pathways in Fanconi s anemia and breast cancer D'Andrea ADN Engl J Med 2010[May]; 362 (20): 1909-19The study of rare genetic diseases can lead to insights into the cause and treatment of common diseases. An example is the rare chromosomal instability disorder, Fanconi Anemia (FA). Studies of this disease have elucidated general mechanisms of bone marrow failure, cancer pathogenesis, and resistance to chemotherapy. The principal features of FA are aplastic anemia in childhood, susceptibility to cancer or leukemia, and hypersensitivity of FA cells to DNA cross-linking agents. There are thirteen FA genes, and one of these genes is identical to the well known breast cancer susceptibility gene, BRCA2. The corresponding FA proteins cooperate in the recognition and repair of damaged DNA. Inactivation of FA genes occurs not only in FA patients but also in a variety of cancers in the general population. These findings have broad implications for predicting the sensitivity and resistance of tumors to conventional anti-cancer agents, to inhibitors of poly-ADP ribose polymerase 1, an enzyme involved in DNA repair, and to other inhibitors of DNA repair.|*Genes, BRCA2[MESH]|*Genetic Predisposition to Disease[MESH]|*Germ-Line Mutation[MESH]|Breast Neoplasms/*genetics[MESH]|DNA Methylation[MESH]|DNA Repair/*physiology[MESH]|Epigenesis, Genetic[MESH]|Fanconi Anemia Complementation Group Proteins/*genetics/metabolism/physiology[MESH]|Fanconi Anemia/diagnosis/*genetics/therapy[MESH]|Female[MESH]|Humans[MESH]|Metabolic Networks and Pathways[MESH]|Mutation[MESH]|Ovarian Neoplasms/genetics[MESH] |